| Data from 2101 patients and 3521 eyes treated with LipiFlow indicate that a single 12-min LipiFlow treatment safely improves signs and symptoms of meibomian gland dysfunction. |
| The benefits of a single LipiFlow persist up to 3 years in some cases. |
| The majority of studies evaluating safety reported no discomfort or pain associated with LipiFlow treatment, which supports the patient acceptability of LipiFlow therapy. |
| While some studies showed that compliant daily eyelid hygiene, warm compress, and/or massage had a similar benefit to a single LipiFlow, these treatments were limited by inconvenience, discomfort, and non-compliance. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.